A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss ...

Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. PMC-403 is being explored in broader therapeutic ...

Neovascular age-related macular degeneration is responsible for the overwhelming majority of vision loss in age-related macular degeneration. Not too long ago, the disease was poorly controlled ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

Opens in a new tab or window CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration (AMD) suggested a potential annual savings ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...